These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30427550)

  • 1. Population Pharmacokinetics of Adjunctive Lacosamide in Pediatric Patients With Epilepsy.
    Winkler J; Schoemaker R; Stockis A
    J Clin Pharmacol; 2019 Apr; 59(4):541-547. PubMed ID: 30427550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in children.
    Winkler J; Schoemaker R; Stockis A
    Epilepsy Res; 2019 Jan; 149():13-16. PubMed ID: 30415109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Real-World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under 4 Years of Age.
    Lukka PB; Woods M; Chhim R; Phelps SJ; Wheless JW; Meibohm B
    J Clin Pharmacol; 2021 Jul; 61(7):881-888. PubMed ID: 33599301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Schoemaker R; Wade JR; Stockis A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):727-733. PubMed ID: 28280887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age and sex on lacosamide pharmacokinetics in healthy adult subjects and adults with focal epilepsy.
    Schaefer C; Cawello W; Waitzinger J; Elshoff JP
    Clin Drug Investig; 2015 Apr; 35(4):255-65. PubMed ID: 25708532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages.
    May TW; Helmer R; Bien CG; Brandt C
    Ther Drug Monit; 2018 Oct; 40(5):620-627. PubMed ID: 30086089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?
    Schultz L; Mahmoud SH
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):315-349. PubMed ID: 31950342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
    Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
    Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy upon 12-weeks after achievement of maximal dose and tolerability of lacosamide as an adjunctive therapy in epilepsy: Real world clinical experience.
    Chang RS; Lui HKK; Lui HTC; Leung CYW; Leung YHI; Wang YO
    J Neurol Sci; 2020 Feb; 409():116601. PubMed ID: 31801052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway.
    Larsen Burns M; Nikanorova M; Baftiu A; Borg Rasmussen J; Johannessen SI; Johannessen Landmark C
    Ther Drug Monit; 2019 Jun; 41(3):340-347. PubMed ID: 30688870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic Models.
    Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
    J Clin Pharmacol; 2021 May; 61(5):677-687. PubMed ID: 33244764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy.
    May TW; Brandt C; Helmer R; Bien CG; Cawello W
    Epilepsia; 2015 Jul; 56(7):1134-40. PubMed ID: 25988882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.
    Rodrigues C; Chhun S; Chiron C; Dulac O; Rey E; Pons G; Jullien V
    Eur J Clin Pharmacol; 2018 Jun; 74(6):793-803. PubMed ID: 29564480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.